SS
Sonal Singh
About Sonal Singh
Data last updated:
Sonal Singh has 7 years in corporate governance. Holds Director and Individual Subscriber roles. Currently with 2 companies, including Glasgow Hospital Private Limited and Wellvion Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Glasgow Hospital Private Limited at ₹28.76 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Mar 2019 | 2018 | ₹28.76 Cr (FY 2025) | Active | |
| Individual Subscriber | 20 Jun 2026 | 2026 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sonal Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sonal Singh
Sonal Singh has 7 years in corporate governance. Holds Director and Individual Subscriber roles. Currently with 2 companies, including Glasgow Hospital Private Limited and Wellvion Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Glasgow Hospital Private Limited at ₹28.76 Cr (FY 2025).
Sonal Singh is associated with 2 companies as Director and Individual Subscriber, including Glasgow Hospital Private Limited (₹28.76 Cr), Wellvion Pharma Private Limited.
Sonal Singh has expertise in General Business.
Sonal Singh has 7 years in corporate governance.
By reported revenue, the largest current company of Sonal Singh is Glasgow Hospital Private Limited, with revenue of ₹28.76 Cr (FY 2025).
Sonal Singh currently holds positions at 2 companies: Glasgow Hospital Private Limited (₹28.76 Cr), Wellvion Pharma Private Limited.